Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,602 | -157,846 | -127,119 | -83,150 | -46,606 |
| Depreciation Amortization | 459 | 3,276 | 2,483 | 1,681 | 843 |
| Accounts receivable | -11,445 | 4,771 | 1,058 | 2,314 | 1,995 |
| Accounts payable and accrued liabilities | -2,461 | 2,462 | -1,217 | -6,083 | -1,247 |
| Other Working Capital | -29,515 | 3,826 | -2,647 | -14,742 | -9,923 |
| Other Operating Activity | 25,230 | 19,676 | 25,459 | 23,040 | 10,843 |
| Operating Cash Flow | $-56,334 | $-123,835 | $-101,983 | $-76,940 | $-44,095 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -264 | -867 | -777 | -561 | -531 |
| Investing Cash Flow | $-264 | $-867 | $-777 | $-561 | $-531 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 271 | 98,217 | 98,174 | 99,053 | 356 |
| Other Financing Activity | 0 | -1,163 | 0 | 0 | 0 |
| Financing Cash Flow | $271 | $97,054 | $98,174 | $99,053 | $356 |
| Exchange Rate Effect | 161 | -83 | 260 | -31 | -43 |
| Beginning Cash Position | 250,867 | 278,598 | 278,598 | 278,598 | 278,598 |
| End Cash Position | 194,701 | 250,867 | 274,272 | 300,119 | 234,285 |
| Net Cash Flow | $-56,166 | $-27,731 | $-4,326 | $21,521 | $-44,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,334 | -123,835 | -101,983 | -76,940 | -44,095 |
| Capital Expenditure | -264 | -867 | -777 | -561 | -531 |
| Free Cash Flow | -56,598 | -124,702 | -102,760 | -77,501 | -44,626 |